Catheter Precision Inc（VTAK）の株価予測VTAKCatheter Precision Inc

Alphio's VTAK stock price prediction model matches the current Catheter Precision Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.20 (+1.06%). The 1-week path is $0.21 (+3.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Given the current price of $0.20, a 90.01% year-to-date decline, and an RSI of 15.422 indicating oversold conditions, VTAK is not a good buy right now. The company has shown some positive revenue growth, but the overall financial health is concerning with a net income loss of $3.04 million in the latest quarter and a gross margin of 90.28%. The main risk is the substantial debt-to-equity ratio of 113.15%, indicating high leverage and financial instability.

Catheter Precision Inc (VTAK) last closed at $0.2007, gaining +1.21%. These facts feed the 1-day and 1-week VTAK price prediction above.